Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Class A Common stock, par value $0.0001 per share
-
Shares outstanding
-
22,440,632
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
1,189,410
-
Shares change
-
+1,179,667
-
Total reported value, excl. options
-
$8,418,000
-
Value change
-
+$8,350,000
-
Put/Call ratio
-
10%
-
Number of buys
-
20
-
Price
-
$7.08
Significant Holders of Celularity Inc - Class A Common stock, par value $0.0001 per share (CELU) as of Q3 2021
34 filings reported holding CELU - Celularity Inc - Class A Common stock, par value $0.0001 per share as of Q3 2021.
Celularity Inc - Class A Common stock, par value $0.0001 per share (CELU) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,189,410 shares
of 22,440,632 outstanding shares and own 5.3% of the company stock.
Largest 10 shareholders include FMR LLC (644,600 shares), HRT FINANCIAL LP (144,837 shares), GEODE CAPITAL MANAGEMENT, LLC (66,554 shares), MORGAN STANLEY (51,000 shares), Verition Fund Management LLC (50,000 shares), Lombard Odier Asset Management (USA) Corp (40,000 shares), CITADEL ADVISORS LLC (33,474 shares), JANE STREET GROUP, LLC (30,636 shares), BlackRock Inc. (25,305 shares), and GROUP ONE TRADING, L.P. (21,249 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.